About Ascendis Pharma A/S (adapted from Ascendis Pharma A/S prospectus):
They are a clinical stage biopharmaceutical company applying their TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.